Pharma-K
Pharma-K is a São Paulo-based specialty pharmaceutical commercializer and distributor founded in 2015, selling high-cost medications across oncology, cardiology, neurology, and other therapeutic areas via three divisions — direct-to-patient delivery, B2B institutional distribution, and medication import advisory — to individuals, hospitals, clinics, health-plan operators, and PBMs in Brazil.
- Company typePrivate
- Founded2015
- HeadquartersSão Paulo, Brazil
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Pharma-K does
Pharma-K (Pharma-K Medicamentos Especiais) is a privately held Brazilian pharmaceutical company founded in 2015 and headquartered at Rua Lincon Albuquerque, 259 — Conj. 23/24, Perdizes, São Paulo, operating under CNPJ 20.506.881/0001-24. The company specializes in the commercialization, distribution, and import-mediated nationalization of high-cost medications across approximately 22 stock-keeping units and 14 therapeutic categories, with oncology, cardiology, neurology, and rheumatology representing the largest categories. Its portfolio spans branded oncology agents (Adcetris, Avastin, Bortezomibe, Erbitux, Glivec, Halaven, Nexavar, Votrient, Xtandi, Zytiga), cardiology products (Clexane, Plavix), neurology treatments (Fingolimode), rheumatology products (Fortéo, Remsima), and a long tail of additional specialty categories.
The company runs a three-division operating model from distinct subdomains. Delivery Pharma-K (pharmak.com.br/loja) is a direct-to-consumer storefront distributing prescription specialty medications to individual patients with home delivery, WhatsApp-based consultation, installment billing (up to 3x interest-free via credit card), and free shipping for the Greater São Paulo region. Pharma-K Distribuidora (distribuidora.pharmak.com.br) is a B2B distribution channel serving hospitals, clinics, health-plan operators, and medication benefit programs. Assessoria (assessoria.pharmak.com.br) provides a professional services arm that imports medications unavailable in Brazil and navigates ANVISA authorization requirements. All products are priced "SOB CONSULTA" (on consultation) with no publicly disclosed fixed pricing.
Pharma-K is certified by ACSA-IBES (international quality standard) and is LGPD-compliant under Lei nº 13.709/2018. The firm employs 51–100 people, has no disclosed funding rounds, no named institutional customers, no M&A or partnership activity on record, and no proprietary software platform or AI capability disclosed. Revenue mechanics rest on transactional pharmaceutical resale (B2C and B2B) supplemented by fee-based import advisory services, with a consultative sales motion (WhatsApp-gated quoting) operating across all three channels.
Pharma-K firmographics
Firmographics- Name
- Pharma-K
- Legal name
- Pharma-K
- Website
- https://pharmak.com.br
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Pharma-K is a São Paulo-based specialty pharmaceutical commercializer and distributor founded in 2015, selling high-cost medications across oncology, cardiology, neurology, and other therapeutic areas via three divisions — direct-to-patient delivery, B2B institutional distribution, and medication import advisory — to individuals, hospitals, clinics, health-plan operators, and PBMs in Brazil.
- Ownership category
- akta.pro rank
Pharma-K industry classification
Industry- Product category
- Specialty Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (4242), Pharmacies and Drug Retailers (45611)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)
- akta.pro secondary industries
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Mail-Order & Home Delivery Pharmacies (HLAFALAD)
Keywords
Where Pharma-K is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Pharma-K business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Revenue model
- Pharmaceutical product sales - Direct to Consumer: Direct sale and delivery of high-cost medications to individual patients (pessoa física) through the company's e-commerce platform and WhatsApp-based consultation system. Sales are conducted on a consultation basis with pricing provided upon inquiry.
- B2B Distribution: Distribution of high-cost medications to hospitals, clinics, health insurance operators and medication benefit programs (PBMs) through the company's dedicated distributor platform (distribuidora.pharmak.com.br).
- Import Advisory Services: Specialized consulting services for importing medications from various parts of the world, focused on products not available in the national market. The company handles ANVISA regulatory processes and authorization requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Consultation-based pricing - no fixed public pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Pharma-K product offering
Product offeringCore offering
Pharma-K is a Brazilian pharmaceutical distribution and commercialization company that supplies high-cost specialty medications to both individual patients and institutional healthcare buyers across oncology, cardiology, neurology, rheumatology, pneumology, anesthesiology, endocrinology, infectology, and gastroenterology. It operates three distinct service lines—Delivery Pharma-K (B2C direct-to-patient with home shipping), Pharma-K Distribuidora (B2B volume distribution to hospitals, clinics, health plan operators, and PBMs), and Pharma-K Assessoria de Importação (consulting and ANVISA regulatory support for importing medications unavailable in Brazil). All transactions are priced on a consultation basis ("SOB CONSULTA") rather than via fixed public price tags.
Product overview
Pharma-K is a Brazilian pharmaceutical company specializing in the commercialization, distribution, and importation of high-cost medications. The company operates through three integrated service divisions: Delivery Pharma-K (direct-to-patient B2C service offering personalized home delivery for individuals), Pharma-K Distribuidora (B2B distribution for hospitals, clinics, and health insurance operators), and Pharma-K Assessoria de Importação (specialized advisory for importing medications not available domestically). The product portfolio includes approximately 22 specialty medications across 14 therapeutic categories including Oncology (Adcetris, Avastin, Bortezomibe, Erbitux, Glivec, Halaven, Imatinib, Nexavar, Votrient, Xtandi, Zytiga), Cardiology (Clexane, Plavix), Neurology (Fingolimode), Rheumatology (Fortéo, Remsima), Pneumology (Giotrif, Singulair), Endocrinology (Metformin), Infectology (Tamiflu), Anesthesiology (Propofol, Rocuronio), and Gastroenterology (Remsima). All products are dispensed with medical prescription and priced "on consultation" (sob consulta).
Differentiator
Problem solved
Functional benefit
Products and services
- Delivery Pharma-K B2C direct delivery service for individual patients (pessoa física) requiring high-cost specialty medications, providing personalized and humanized service from quotation through delivery, with free shipping to Greater São Paulo.
- Pharma-K Distribuidora B2B wholesale distribution service for healthcare institutions supplying high-cost specialty medications to hospitals, clinics, health plan operators (operadoras de planos de saúde), and PBMs.
- Pharma-K Assessoria de Importação Specialized consulting and end-to-end service for importing medications from international sources that are not available in the Brazilian national market, including full ANVISA regulatory navigation and authorization support.
- Adcetris 50mg – frasco IV Anti-CD30 monoclonal antibody (brentuximab vedotin) for intravenous administration, used in Hodgkin lymphoma and systemic anaplastic large cell lymphoma treatment. Prescription specialty medication sold under consultation-based pricing.
- Avastin 100mg – frasco 4ml Bevacizumab anti-VEGF monoclonal antibody for various cancer treatments including colorectal, lung, breast, kidney, and ovarian cancers. Prescription specialty medication.
- Bortezomibe 3,5mg – pó liofilizado Proteasome inhibitor for multiple myeloma treatment, administered as lyophilized powder for injection. Prescription specialty medication.
- Erbitux 5mg/ml – frasco 20ml Cetuximab anti-EGFR monoclonal antibody for colorectal cancer and head and neck squamous cell carcinoma treatment. Prescription specialty medication.
- Glivec 100mg – 60 comprimidos Imatinib tyrosine kinase inhibitor for chronic myeloid leukemia, gastrointestinal stromal tumors, and other cancers. Prescription specialty medication.
- Halaven 1mg/2ml – injetável Eribulin mesylate for metastatic breast cancer and liposarcoma treatment, administered as injectable solution. Prescription specialty medication.
- Imatinibe Mesilato 400mg – 30 comprimidos Imatinib mesylate tablets for chronic myeloid leukemia and gastrointestinal stromal tumor treatment. Prescription specialty medication.
- Nexavar 200mg – 60 comprimidos Sorafenib multikinase inhibitor for renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer treatment. Prescription specialty medication.
- Votrient 400mg – 30 comprimidos Pazopanib tyrosine kinase inhibitor for renal cell carcinoma and soft tissue sarcoma treatment. Prescription specialty medication.
- Xtandi 40mg – 112 cápsulas Enzalutamide androgen receptor inhibitor for prostate cancer treatment. Prescription specialty medication.
- Zytiga 250mg – 120 comprimidos Abiraterone acetate for metastatic castration-resistant prostate cancer treatment. Prescription specialty medication.
- Clexane 40mg – seringa preenchida Enoxaparin low molecular weight heparin for thrombosis prevention, administered via pre-filled syringe. Prescription specialty medication.
- Plavix 75mg – 28 comprimidos Clopidogrel antiplatelet agent for atherosclerosis, heart attack, and stroke prevention. Prescription specialty medication.
- Fingolimode 0,5mg – 28 cápsulas Sphingosine 1-phosphate receptor modulator (fingolimod) for multiple sclerosis treatment. Prescription specialty medication.
- Fortéo Colter Pen 20mcg/dose Teriparatide injection pen for osteoporosis treatment, administered at 20mcg per dose. Prescription specialty medication.
- Remsima 100mg – pó p/ infusão Infliximab biosimilar for rheumatoid arthritis, inflammatory bowel disease, and other autoimmune conditions. Prescription specialty medication.
- Giotrif 40mg – 30 comprimidos Afatinib EGFR tyrosine kinase inhibitor for non-small cell lung cancer treatment. Prescription specialty medication.
- Singulair 10mg – 28 comprimidos Montelukast leukotriene receptor antagonist for asthma and allergic rhinitis treatment. Prescription specialty medication.
- Metformina 850mg – 30 comprimidos Metformin hydrochloride for type 2 diabetes treatment and management. Prescription specialty medication.
- Tamiflu 75mg – 10 cápsulas Oseltamivir neuraminidase inhibitor for influenza treatment and prevention. Prescription specialty medication.
- Propofol 1% – frasco 20ml Intravenous anesthetic agent for induction and maintenance of anesthesia during surgical procedures. Prescription specialty medication.
- Rocuronio 50mg/5ml – solução injetável Neuromuscular blocking agent (rocuronium) for endotracheal intubation and mechanical ventilation during surgery. Prescription specialty medication.
Companies that use Pharma-K
Customer profileSegments3 records
Ideal customer profiles3 records
Pharma-K technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharma-K partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Pharma-K competitors and assessment
Company assessmentBroad incumbents
- Raia Drogasil (RD): Largest pharmacy retail chain in Brazil with growing specialty pharmacy services and digital channels. Comparable as a B2C pharmacy competitor with much greater scale and assortment.
- DPSP (Drogaria Pacheco / Drogaria São Paulo): Large São Paulo–based pharmacy chain with broad specialty drug availability. Comparable on B2C specialty pharmacy in Pharma-K's core São Paulo market.
- Eurofarma: Large Brazilian pharmaceutical company with both manufacturing and distribution of specialty and high-cost medications. Comparable on portfolio breadth across oncology, neurology and rheumatology therapeutic areas.
- Pague Menos: Major Brazilian retail pharmacy chain with nationwide footprint and growing specialty drug and B2B services. Comparable on the consumer-side pharmacy offering and institutional relationships.
- Panvel: Regional pharmacy chain in southern Brazil with growing digital and specialty pharmacy offerings. Comparable on pharmacy retail model with specialty drug focus.
Emerging players
- Biolab: Brazilian specialty pharmaceutical manufacturer with growing presence in oncology, rheumatology and cardiology. Comparable as a domestic specialty pharma player focused on similar therapeutic areas.
Direct peers
- Profarma: Largest pharmaceutical distributor in Brazil, serving retail pharmacies, hospitals and PBMs. Directly comparable to Pharma-K's Distribuidora division in B2B specialty drug distribution.
- Medilar: Specialty pharma distributor serving hospitals, clinics and health plans in Brazil with high-cost medications, including oncology and immunology. Closely mirrors Pharma-K's institutional specialty focus.
- Hospitalar Distribuidora: Brazilian distributor specializing in hospital-channel pharmaceuticals and medical supplies. Comparable on the institutional/B2B distribution of specialty medications to hospitals and clinics.
- CM Hospitalar: Brazilian specialty pharmaceutical distributor focused on high-cost and hospital-channel medications, including oncology and biologics. Directly comparable on specialty distribution model and institutional customer base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Pharma-K social profiles
Digital presencePharma-K compliance and trust
Trust signalCompliance2 records
Pharma-K financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharma-K leadership team
Management profileNumber of profiles
Pharma-K funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharma-K M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharma-K
What does Pharma-K do?
Pharma-K is a Brazilian pharmaceutical distribution and commercialization company that supplies high-cost specialty medications to both individual patients and institutional healthcare buyers across oncology, cardiology, neurology, rheumatology, pneumology, anesthesiology, endocrinology, infectology, and gastroenterology. It operates three distinct service lines—Delivery Pharma-K (B2C direct-to-patient with home shipping), Pharma-K Distribuidora (B2B volume distribution to hospitals, clinics, health plan operators, and PBMs), and Pharma-K Assessoria de Importação (consulting and ANVISA regulatory support for importing medications unavailable in Brazil). All transactions are priced on a consultation basis ("SOB CONSULTA") rather than via fixed public price tags.
Is Pharma-K a public or private company?
Pharma-K is a private company. It is classified as unknown and is currently operating.
When was Pharma-K founded?
Pharma-K was founded in 2015. It employs 51 to 100 people.
Where is Pharma-K based?
Pharma-K is headquartered in São Paulo, Brazil, in the Latin America region.
How does Pharma-K make money?
Three revenue lines are on record. Pharmaceutical product sales - Direct to Consumer is the primary driver. The others are B2B Distribution and import Advisory Services.
Who are Pharma-K's main competitors?
Broad incumbents on record are Raia Drogasil (RD), DPSP (Drogaria Pacheco / Drogaria São Paulo), Eurofarma, Pague Menos and Panvel. Biolab is listed as an emerging player. Direct peers are Profarma, Medilar, Hospitalar Distribuidora and CM Hospitalar.
Does Pharma-K have an API?
No public API is recorded for Pharma-K.
What industry is Pharma-K in?
Pharma-K's product category is Specialty Pharmaceutical Distribution. Its primary akta.pro industry code is HLAFALAC, Specialty Pharmacies (Complex/High-Cost Therapies), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 4242 and its SIC code is 5122.